To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Federal Drug Control Programs, High Intensity Drug Trafficking Areas Program for fiscal year 2024.

HR 2072 sets a spending cap of $280 million for specific federal drug control programs in fiscal year 2024. It directly limits funding for the Executive Office of the President's drug policy functions, the Office of National Drug Control Policy, Federal Drug Control Programs, and High Intensity Drug Trafficking Areas Program. The bill prevents these programs from using more than $280 million in available funds for FY2024. This is a direct budgetary restriction on federal drug control initiatives.